Clinical Trial Update: Naltrexone in AUD Reward Drinkers [Phase 4]

View source ↗

Summary

Phase 4 trial sponsored by the University of Pennsylvania evaluating naltrexone for reward-driven drinking in Alcohol Use Disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Alcohol Use Disorder, Alcoholism | Phase 4 | Status: RECRUITING